Published in J Acquir Immune Defic Syndr on March 01, 2005
Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. AIDS (2007) 1.28
Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239. J Med Primatol (2007) 0.98
Contraception and HIV infection in women. Hum Reprod Update (2008) 0.85
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet (1999) 18.20
HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA (2000) 8.45
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr (1991) 7.05
Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis (1999) 6.85
The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. Am J Public Health (1987) 5.78
Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med (1996) 5.77
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS (2001) 5.31
Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet (2001) 5.10
Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA (1992) 4.77
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med (2001) 4.68
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet (1999) 4.61
Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol (2000) 3.83
Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study. Br J Obstet Gynaecol (1996) 3.62
The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiol Rev (2004) 3.41
Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis (2000) 3.02
Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis (1998) 2.96
Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol (1999) 2.90
The San Francisco Men's Health Study: continued decline in HIV seroconversion rates among homosexual/bisexual men. Am J Public Health (1988) 2.69
Cot mattresses and sudden infant death syndrome. Lancet (1995) 2.60
Risk factors for HIV infection among young adult men in northern Thailand. JAMA (1993) 2.53
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS (2000) 2.49
Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet (1986) 2.43
Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother (2002) 2.43
Interorganizational relationships among HIV/AIDS service organizations in Baltimore: a network analysis. J Urban Health (2001) 2.43
Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis (1998) 2.40
Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol (2003) 2.32
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS (1999) 2.23
Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin Infect Dis (2000) 2.21
Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS (1995) 2.19
The epidemiology of HIV and syphilis among male commercial sex workers in northern Thailand. AIDS (1995) 2.12
The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. Am J Community Psychol (1996) 2.07
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis (1999) 2.06
Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis (1997) 2.02
Comorbidities among HIV-infected injection drug users in Chennai, India. Indian J Med Res (2008) 1.95
Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol (2001) 1.95
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study). J Infect Dis (2001) 1.93
A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis. Tuber Lung Dis (1995) 1.85
Acceptability of the female condom among sex workers in Thailand: results from a prospective study. Sex Transm Dis (2001) 1.78
Illicit drug use in one's social network and in one's neighborhood predicts individual heroin and cocaine use. Ann Epidemiol (2001) 1.77
Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS (2001) 1.75
Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis (1998) 1.74
Human immunodeficiency virus infection and self-treatment for sexually transmitted diseases among northern Thai men. Sex Transm Dis (1996) 1.72
Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect (2014) 1.71
Correlates of AIDS knowledge in samples of the general population. Soc Sci Med (1993) 1.70
Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS (2000) 1.70
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68
N-Acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. I. Partial purification and relation to amoebic virulence in vitro. J Infect Dis (1985) 1.67
Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health (2001) 1.67
Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica. J Immunol (1986) 1.65
Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol (1990) 1.65
A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin Infect Dis (1999) 1.64
Inner-city women at risk for cervical cancer: behavioral and utilization factors related to inadequate screening. Prev Med (1990) 1.63
A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS (1993) 1.63
Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr (2001) 1.63
Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis (1995) 1.62
Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol (1991) 1.62
Norwegian scabies and a toxic shock syndrome toxin 1-producing strain of Staphylococcus aureus endocarditis in a patient with trisomy 21. Clin Infect Dis (1998) 1.60
Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J Travel Med (1999) 1.59
Targeting AIDS prevention and treatment toward HIV-1-infected persons. The concept of early intervention. JAMA (1989) 1.59
Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug Alcohol Depend (2001) 1.57
An epidemiologic study of headache among adolescents and young adults. JAMA (1989) 1.57
Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis (1999) 1.54
Cancer preventive screening behavior among elderly women. Prev Med (1982) 1.53
Invasive infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis (1990) 1.49
Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage. J Clin Invest (1985) 1.49
Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999. Clin Infect Dis (2000) 1.47
Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health (1999) 1.47
Multiple condom use in commercial sex in Lamphun Province, Thailand: a community-generated STD/HIV prevention strategy. Sex Transm Dis (1997) 1.46
Selected sexual practices of San Francisco heterosexual men and risk of infection by the human immunodeficiency virus. JAMA (1987) 1.45
Decreased incidence of sexually transmitted diseases among trucking company workers in Kenya: results of a behavioural risk-reduction programme. AIDS (1997) 1.45
Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand. HIV Med (2004) 1.45
Alcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infection. Sex Transm Dis (1994) 1.45
Variation in the duration of protection given by screening using the Pap test for cervical cancer. J Clin Epidemiol (1989) 1.44
Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis (1999) 1.44
The use of condoms with other contraceptive methods among young men and women. Fam Plann Perspect (1998) 1.44
Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Educ Prev (1998) 1.43
A new method for measuring eosinophil activating factors, based on the increased expression of CR3 alpha chain (CD11b) on the surface of activated eosinophils. J Immunol Methods (1990) 1.42
Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol (1991) 1.41
Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis (2000) 1.41
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol (1989) 1.39
Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA (1993) 1.38
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. J Virol (1999) 1.37
The interaction of human neutrophils and Entamoeba histolytica increases cytopathogenicity for liver cell monolayers. J Infect Dis (1986) 1.36
Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med (1992) 1.36
Epidemiologic evidence for time variation in HIV infectivity. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.35
Practice changes in response to the malpractice litigation climate. Results of a Maryland physician survey. Med Care (1989) 1.34
HIV testing men in the antenatal setting: understanding male non-disclosure. Int J STD AIDS (2009) 1.34
Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials. J Acquir Immune Defic Syndr (2000) 1.33
Same-sex behavior, sexually transmitted diseases and HIV risks among young northern Thai men. AIDS (1995) 1.32
Managing HIV among serodiscordant heterosexual couples: serostatus, stigma and sex. AIDS Care (1998) 1.32
Perceptions of community- and family-level injection drug user (IDU)- and HIV-related stigma, disclosure decisions and experiences with layered stigma among HIV-positive IDUs in Vietnam. AIDS Care (2011) 1.31
The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health (2000) 1.30
Gang exposure and pregnancy incidence among female adolescents in San Francisco: evidence for the need to integrate reproductive health with violence prevention efforts. Am J Epidemiol (2008) 1.30
Cot mattress biodeterioration and SIDS. Lancet (1990) 1.29
Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg (1985) 1.29